Loading...
Loading...
Novartis
NVS reported a 16.6% drop in its net profit for the first quarter.
Novartis' quarterly net profit declined to $2.31 billion, from $2.77 billion, in the year-ago quarter. However, analysts were expecting a net profit of $2.16 billion. Its net sales fell 2% at $13.74 billion
Sales at the flagship pharmaceuticals division climbed 1.8% to $7.84 billion.
Novartis shares closed at $55.62 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in